Corrigendum: Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma

Detalles Bibliográficos
Autores principales: Shi, Jingzhen, Zhang, Yingjie, Wang, Jinzhi, Li, Jianbin, Li, Zhenxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716789/
https://www.ncbi.nlm.nih.gov/pubmed/33330061
http://dx.doi.org/10.3389/fonc.2020.583499
_version_ 1783619231529566208
author Shi, Jingzhen
Zhang, Yingjie
Wang, Jinzhi
Li, Jianbin
Li, Zhenxiang
author_facet Shi, Jingzhen
Zhang, Yingjie
Wang, Jinzhi
Li, Jianbin
Li, Zhenxiang
author_sort Shi, Jingzhen
collection PubMed
description
format Online
Article
Text
id pubmed-7716789
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-77167892020-12-15 Corrigendum: Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma Shi, Jingzhen Zhang, Yingjie Wang, Jinzhi Li, Jianbin Li, Zhenxiang Front Oncol Oncology Frontiers Media S.A. 2020-11-20 /pmc/articles/PMC7716789/ /pubmed/33330061 http://dx.doi.org/10.3389/fonc.2020.583499 Text en Copyright © 2020 Shi, Zhang, Wang, Li and Li. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Shi, Jingzhen
Zhang, Yingjie
Wang, Jinzhi
Li, Jianbin
Li, Zhenxiang
Corrigendum: Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma
title Corrigendum: Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma
title_full Corrigendum: Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma
title_fullStr Corrigendum: Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma
title_full_unstemmed Corrigendum: Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma
title_short Corrigendum: Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma
title_sort corrigendum: anlotinib combined with chemoradiotherapy exhibits significant therapeutic efficacy in esophageal squamous cell carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716789/
https://www.ncbi.nlm.nih.gov/pubmed/33330061
http://dx.doi.org/10.3389/fonc.2020.583499
work_keys_str_mv AT shijingzhen corrigendumanlotinibcombinedwithchemoradiotherapyexhibitssignificanttherapeuticefficacyinesophagealsquamouscellcarcinoma
AT zhangyingjie corrigendumanlotinibcombinedwithchemoradiotherapyexhibitssignificanttherapeuticefficacyinesophagealsquamouscellcarcinoma
AT wangjinzhi corrigendumanlotinibcombinedwithchemoradiotherapyexhibitssignificanttherapeuticefficacyinesophagealsquamouscellcarcinoma
AT lijianbin corrigendumanlotinibcombinedwithchemoradiotherapyexhibitssignificanttherapeuticefficacyinesophagealsquamouscellcarcinoma
AT lizhenxiang corrigendumanlotinibcombinedwithchemoradiotherapyexhibitssignificanttherapeuticefficacyinesophagealsquamouscellcarcinoma

Ejemplares similares